Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-97-002856
Filing Date
1997-06-27
Accepted
1997-06-27 00:00:00
Documents
12
Period of Report
1997-03-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 ALKERMES FORM 10-K 10-K 217701
2 AMENDED & RESTATED 1990 OMNIBUS STOCK OPITION PLAN EX-10.2 26741
3 LEASE DATED 7/26/93 EX-10.8 134042
4 1 ST AMENDMENT TO LEASE EX-10.8(A) 79247
5 2ND AMENDMENT TO DEVELOPMENT AGREEMENT EX-10.22(B) 9567
6 LOAN SUPPLEMENT & MODIFICATION AGREEMENT EX-10.27(A) 92753
7 PROMISSORY NOTE DATED 6/2/97 EX-10.35 8049
8 STATEMENT RE: COMPUTATION OF PER SHARE EARNINGS EX-11 1734
9 SUBSIDIARIES OF THE REGISTRANT EX-21 869
10 PROXY STATEMENT DATED JUNE 1997 EX-22 71333
11 CONSENT OF DELOITTE & TOUCHE EX-23 539
12 FINNACIAL DATA SCHEDULE EX-27 2282
  Complete submission text file 0000950135-97-002856.txt   647391
Mailing Address
Business Address 64 SIDNEY ST CAMBRIDGE MA 02139-4136 6174940171
ALKERMES INC (Filer) CIK: 0000874663 (see all company filings)

EIN.: 232472830 | State of Incorp.: PA | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 000-19267 | Film No.: 97631829
SIC: 2834 Pharmaceutical Preparations